Nan­cy Stagliano bags an­oth­er $45M for True North’s rare dis­ease R&D

Nan­cy Stagliano has a habit of re­main­ing pre­cise­ly on mes­sage when she talks about South San Fran­cis­co-based True North Ther­a­peu­tics.

Her new $45 mil­lion round …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.